$ORGO 2025—fueled by game-changing acquisition in regen med! Boosts market share, innovation pipeline, and Q4 EPS beat (4¢ vs 2¢ exp). Revenue hit $126M, proving resilience. Don't sleep on this turnaround story! #StockSurge #ORGO

Nov 7, 2025 · 2:53 PM UTC